These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 37291935

  • 1. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].
    Zhang YJ, Ma JY, Liu XY, Zheng DF, Zhang YS, Li XG, Fan DS.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun 18; 55(3):558-562. PubMed ID: 37291935
    [Abstract] [Full Text] [Related]

  • 2. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 18; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 3. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
    Khan F, Brady S, Kuttikat A.
    Rheumatol Int; 2023 Feb 18; 43(2):383-390. PubMed ID: 36260115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S, Parekh JD, Chilukuri RS, Andukuri VA.
    Drug Discov Ther; 2018 Feb 18; 12(5):315-317. PubMed ID: 30464165
    [Abstract] [Full Text] [Related]

  • 9. Unveiling the Rare Complication: Statin-Induced Immune-Mediated Necrotizing Myopathy.
    Chowdhury FH, Mahneva O, Maharaj M, Marciales W.
    Am J Case Rep; 2023 Dec 13; 24():e941387. PubMed ID: 38087774
    [Abstract] [Full Text] [Related]

  • 10. [Retrospective study on clinical manifestation, thigh MRI and electrophysiology characteristics of immune-mediated necrotizing myopathy].
    Qiao LY, Shi Q, Lin MY, Liu J, Chen ZJ, Pu C.
    Zhonghua Nei Ke Za Zhi; 2022 Oct 01; 61(10):1144-1151. PubMed ID: 36207969
    [Abstract] [Full Text] [Related]

  • 11. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.
    Medicine (Baltimore); 2015 Jan 01; 94(4):e416. PubMed ID: 25634171
    [Abstract] [Full Text] [Related]

  • 12. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M, Fite C, Kottler D, Maisonobe L, Dossier A, Deschamps L, Descamps V.
    Ann Dermatol Venereol; 2019 Sep 01; 146(8-9):550-556. PubMed ID: 30929872
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
    Torri F, Ali G, Chico L, Siciliano G, Ricci G.
    Acta Myol; 2021 Jun 01; 40(2):105-108. PubMed ID: 34355128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data.
    Rademacher JG, Glaubitz S, Zechel S, Oettler M, Tampe B, Schmidt J, Korsten P.
    Clin Exp Rheumatol; 2022 Feb 01; 40(2):320-328. PubMed ID: 35225222
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.